Patrick A Arensdorf

This inventor holds 20 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Epigenetic Analysis. Top assignees: Intersect Ent Gmbh, Clearnote Health, Inc., Tethys Bioscience, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick A Arensdorf. Retrieved from https://idiyas.com/inventor/patrick-a-arensdorf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 12)

% Patents Active = 65.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 13)

Average Co-Inventor Count = 3.5

ph-index = 10

Forward Citations = 611(Granted Patents)

Company Filing History:

Clearnote Health, Inc.

patents

3 out of 6

Tethys Bioscience, Inc.

patents

4. 1 out of 1

Bluestar Genomics, Inc.

patent

5. 1 out of 3

Health Diagnostic Laboratory, Inc.

patents

6. 1 out of 1

Health Diagnostics Laboratory, Inc.

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Cell-Free DNA

Hydroxymethylation

Epigenetic Analysis

Biomarkers

Paranasal Sinus

Nucleic Acids

Active Agents

Arteriovascular Events

Diabetes

Biological Samples

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760374 - Cell-free DNA hydroxymethylation profiles in the evaluation of pancreatic lesions (2026-10-13),

2. 12584162 - Hydroxymethylation analysis of cell-free nucleic acid samples for assigning tissue of origin, and related methods of use (2026-03-24),

3. 12540319 - SIMULTANEOUS, SEQUENCING-BASED ANALYSIS OF PROTEINS, NUCLEOSOMES, AND CELL-FREE NUCLEIC ACIDS FROM A SINGLE BIOLOGICAL SAMPLE (2026-02-03),

4. 12351859 - Methods for the epigenetic analysis of DNA, particularly cell-free DNA (2025-07-08),

5. 11634748 - Methods for the epigenetic analysis of DNA, particularly cell-free DNA (2023-04-25),

6. 11274335 - Methods for the epigenetic analysis of DNA, particularly cell-free DNA (2022-03-15),

7. 11123091 - Device and methods for treating paranasal sinus conditions (2021-09-21),

8. 9689880 - Markers associated with arteriovascular events and methods of use thereof (2017-06-27),

9. 9585681 - Device and methods for treating paranasal sinus conditions (2017-03-07),

10. 9057736 - Markers associated with arteriovascular events and methods of use thereof (2015-06-16),

11. 9034585 - Diabetes-related biomarkers and methods of use thereof (2015-05-19),

12. 8858974 - Device and methods for treating paranasal sinus conditions (2014-10-14),

13. 8802131 - Devices and methods for delivering active agents to the osteomeatal complex (2014-08-12),

14. 8740839 - Device and methods for treating paranasal sinus conditions (2014-06-03),

15. 8535707 - Devices and methods for delivering active agents to the osteomeatal complex (2013-09-17),

Title: The Innovative Journey of Patrick A Arensdorf

Introduction: Patrick A Arensdorf is a renowned inventor based in Palo Alto, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Patrick A Arensdorf holds several patents in the fields of technology, healthcare, and sustainability, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Patrick A Arensdorf has worked with leading companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Patrick A Arensdorf has collaborated with top researchers, engineers, and scientists to bring his ideas to life, leading to successful partnerships and game-changing inventions.

Conclusion: Patrick A Arensdorf's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.